Raras
Buscar doenças, sintomas, genes...
Síndrome de epilepsia rolândica-dispraxia da fala
ORPHA:163721CID-10 · G40.8CID-11 · 8A61.2YPCDT · SUSDOENÇA RARA

Uma epilepsia rara e genética caracterizada por problemas de fala (que podem ir desde fala arrastada ou dificuldade para articular as palavras, dificuldade em coordenar os movimentos para falar, atraso ou perda da capacidade de entender e se expressar, perda da fala que já se tinha, até dificuldades mais leves na conversa do dia a dia) e por crises epilépticas (que geralmente começam na infância, na maioria das vezes focais — quando afetam uma parte específica do cérebro — ou que começam em uma parte e depois se espalham, e às vezes vêm acompanhadas de aura — um tipo de aviso antes da crise). Dificuldade intelectual, que pode variar de leve a grave, também pode ser observada.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma epilepsia rara e genética caracterizada por problemas de fala (que podem ir desde fala arrastada ou dificuldade para articular as palavras, dificuldade em coordenar os movimentos para falar, atraso ou perda da capacidade de entender e se expressar, perda da fala que já se tinha, até dificuldades mais leves na conversa do dia a dia) e por crises epilépticas (que geralmente começam na infância, na maioria das vezes focais — quando afetam uma parte específica do cérebro — ou que começam em uma parte e depois se espalham, e às vezes vêm acompanhadas de aura — um tipo de aviso antes da crise). Dificuldade intelectual, que pode variar de leve a grave, também pode ser observada.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
277
pacientes catalogados
Início
Antenatal
+ infancy, neonatal
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G40.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
7 sintomas
🫘
Rins
1 sintomas
😀
Face
1 sintomas
👂
Ouvidos
1 sintomas
🦴
Ossos e articulações
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

90%prev.
Atraso no desenvolvimento da fala e da linguagem
Muito frequente (99-80%)
90%prev.
Convulsão
Muito frequente (99-80%)
90%prev.
Apraxia da fala
Muito frequente (99-80%)
55%prev.
Crise tônico-clônica bilateral com início focal
Frequente (79-30%)
55%prev.
Crise de início focal
Frequente (79-30%)
55%prev.
Espículas e ondas contínuas durante o sono lento
Frequente (79-30%)
20sintomas
Muito frequente (3)
Frequente (7)
Ocasional (8)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 20 características clínicas mais associadas, ordenadas por frequência.

Atraso no desenvolvimento da fala e da linguagemDelayed speech and language development
Muito frequente (99-80%)90%
ConvulsãoSeizure
Muito frequente (99-80%)90%
Apraxia da falaSpeech apraxia
Muito frequente (99-80%)90%
Crise tônico-clônica bilateral com início focalBilateral tonic-clonic seizure with focal onset
Frequente (79-30%)55%
Crise de início focalFocal-onset seizure
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Últimos 10 anos6publicações
Pico20162 papers
Linha do tempo
2025Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, X-linked dominant.

SRPX2Sushi repeat-containing protein SRPX2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a ligand for the urokinase plasminogen activator surface receptor. Plays a role in angiogenesis by inducing endothelial cell migration and the formation of vascular network (cords). Involved in cellular migration and adhesion. Increases the phosphorylation levels of FAK. Interacts with and increases the mitogenic activity of HGF. Promotes synapse formation. May have a role in the perisylvian region, critical for language and cognitive development

LOCALIZAÇÃO

SecretedCytoplasmCell surfaceSynapse

MECANISMO DE DOENÇA

Rolandic epilepsy, impaired intellectual development, and speech dyspraxia, X-linked

A condition characterized by the association of rolandic seizures with oral and speech dyspraxia, and intellectual disability. Rolandic seizures occur during a period of significant brain maturation. During this time, dysfunction of neural network activities such as focal discharges may be associated with specific developmental disabilities resulting in specific cognitive impairments of language, visuo-spatial abilities or attention.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
40.5 TPM
Fibroblastos
35.2 TPM
Adipose Visceral Omentum
34.4 TPM
Nervo tibial
29.5 TPM
Mama
21.9 TPM
OUTRAS DOENÇAS (4)
rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linkedrolandic epilepsy-speech dyspraxia syndromeself-limited epilepsy with centrotemporal spikesbilateral perisylvian polymicrogyria
HGNC:30668UniProt:O60687
GRIN2AGlutamate receptor ionotropic, NMDA 2ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of N-methyl-D-aspartate (NMDA) receptors (NMDARs) that function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+) (PubMed:20890276, PubMed:23933818, PubMed:23933819, PubMed:23933820, PubMed:24504326, PubMed:26875626, PubMed:26919761, PubMed:28242877, PubMed:36117210, PubMed:38538865, PubMed:8768735). NMDARs participate in synaptic plasticity for learning and memory formation by contributing to the slow phase of excita

LOCALIZAÇÃO

Cell projection, dendritic spineCell membraneSynapsePostsynaptic cell membraneCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (1)
Assembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Epilepsy, focal, with speech disorder and with or without impaired intellectual development

An autosomal dominant, highly variable neurologic disorder. Features range from severe early-onset seizures associated with delayed psychomotor development, persistent speech difficulties, and intellectual disability to a more benign entity characterized by childhood onset of mild or asymptomatic seizures associated with transient speech difficulties followed by remission of seizures in adolescence and normal psychomotor development. The disorder encompasses several clinical entities, including Landau-Kleffner syndrome, epileptic encephalopathy with continuous spike and wave during slow-wave sleep, autosomal dominant rolandic epilepsy, intellectual disability and speech dyspraxia, and benign epilepsy with centrotemporal spikes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
17.0 TPM
Cérebro - Hemisfério cerebelar
14.8 TPM
Cerebelo
12.7 TPM
Córtex cerebral
11.3 TPM
Brain Anterior cingulate cortex BA24
7.2 TPM
OUTRAS DOENÇAS (5)
early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutationdevelopmental and/or epileptic encephalopathy with spike-wave activation in sleeprolandic epilepsy-speech dyspraxia syndromeself-limited epilepsy with centrotemporal spikes
HGNC:4585UniProt:Q12879

Variantes genéticas (ClinVar)

843 variantes patogênicas registradas no ClinVar.

🧬 GRIN2A: NM_001134407.3(GRIN2A):c.2011_2012del (p.Gln671fs) ()
🧬 GRIN2A: NM_001134407.3(GRIN2A):c.3447C>A (p.Asp1149Glu) ()
🧬 GRIN2A: NM_001134407.3(GRIN2A):c.4014dup (p.Lys1339fs) ()
🧬 GRIN2A: NM_001134407.3(GRIN2A):c.3406G>T (p.Val1136Phe) ()
🧬 GRIN2A: NM_001134407.3(GRIN2A):c.1382T>G (p.Ile461Ser) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de epilepsia rolândica-dispraxia da fala

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

A Novel Candidate Neuromarker of Central Motor Dysfunction in Childhood Apraxia of Speech.

The Journal of neuroscience : the official journal of the Society for Neuroscience2025 May 07

Childhood apraxia of speech (CAS) is conceived as an impairment of the central motor system's ability to program multiple speech movements, resulting in inaccurate transitions between and relative timing across speech sounds. However, the extant neuroimaging evidence base is scant and inconclusive, and the neurophysiological origins of these motor planning problems remain highly underspecified. In the first magnetoencephalography study of this disorder, we measured brain activity from typically developing (TD) children (N = 19, 11 males, 8 females) and children with CAS (N = 7 males) during performance of a speech task designed to interrogate function of the speech areas of the primary sensorimotor cortex. Relative to their TD peers, our sample of children with CAS showed abnormal speech-related responses within the mu-band motor rhythm, and beamformer source reconstruction analyses specify a brain origin of this speech rhythm in the left cerebral hemisphere, within or near pre-Rolandic motor areas crucial for the planning and control of speech and oromotor movements. These results provide a new and specific candidate mechanism for the core praxic features of CAS; point to a novel and robust neurophysiological marker of typical and atypical expressive speech development; and support an emerging neuroscientific consensus which assigns a central role for programming and coordination of speech movements to the motor cortices of the precentral gyrus.

#2

Gerstmann's Syndrome and Limb Apraxia: A Single Case Study.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2025 Nov 24

Gerstmann's syndrome (GS) represents a still debated clinical condition, in terms of both symptoms' evolution and neural correlates. In depth, repeated neuropsychological assessments along with advanced methods of lesion analysis can contribute to a better understanding of the syndrome and clinical diagnosis. The study reports a patient suffering from GS and limb apraxia following a left hemisphere lesion. Two in-depth assessments, at two and four months from the lesion onset, in addition to video material, document the symptoms over time. An in-depth analysis of the grey and white matter lesions was carried out with 3D reconstruction and a disconnection map. The patient shows the characteristic tetrad of GS symptoms in both subacute and chronic phases, in the absence of other clinically relevant sensorimotor or cognitive deficits. Limb apraxia persists over time as well. The neuroanatomical investigation shows the involvement of cortical damage in the inferior parietal cortex that extends to the superior parietal cortex, anteriorly to the peri-rolandic area and medially to the precuneus. Furthermore, disconnections in the fronto-parietal networks and the corpus callosum were identified. This single case study supports previous neuropsychological evidence and neuroanatomical findings on healthy participants, suggesting a core neural network underlying the four GS symptoms, which involves the left superior parietal lobe, the intraparietal cortices and the white matter parietal and fronto-parietal tracts. Furthermore, the involvement of the three branches of the superior longitudinal fasciculus explains the co-occurrence of limb apraxia.

#3

Symptomatology and Neuropathology of patients presenting with focal cortical signs.

Neuropathology : official journal of the Japanese Society of Neuropathology2023 Feb

Here, we describe two patients who presented with focal cortical signs and underwent neuropathological examination. Case 1 was a 73-year-old woman with progressive speech disorder and abnormal behavior. She showed agraphia of the frontal lobe type, featured by the omission of kana letters when writing, other than pyramidal tract signs, pseudobulbar palsy, and frontal lobe dementia. Neuropathological examination, including TAR DNA-binding protein 43 (TDP-43) immunohistochemistry, revealed bilateral frontal and anterior temporal lobe lesions accentuated in the precentral gyrus and posterior part of the middle frontal gyrus. Both upper and lower motor neurons showed pathological changes compatible with amyotrophic lateral sclerosis. Case 2 was a 62-year-old man with progressive speech disorder and hand clumsiness. He had a motor speech disorder, compatible with apraxia of speech, and limb apraxia of the limb-kinetic and ideomotor type. Neuropathological examination revealed degeneration in the left frontal lobe, including the precentral gyrus, anterior temporal, and parietal lobe cortices. Moreover, numerous argyrophilic neuronal intracytoplasmic inclusions (Pick body) and ballooned neurons were observed in these lesions and the limbic system. The pathological diagnosis was Pick disease involving the peri-Rolandic area and parietal lobe. In these two cases, the distribution of neuropathological changes in the cerebral cortices correlated with the clinical symptoms observed.

#4

Oral dyspraxia in self-limited epilepsy with centrotemporal spikes: a comparative study with a control group.

Arquivos de neuro-psiquiatria2021 Dec

self-limited epilepsy with centrotemporal spikes, previously considered benign focal childhood epilepsy with centrotemporal spikes show clinical signs of involvement of Rolandic areas, mainly lower area, which may affect the planning and execution of motor sequences. This study aimed to evaluated oral praxis in children with self-limited epilepsy with centrotemporal spikes and compare to the age-matched control group. This was a descriptive study with 74 children with self-limited epilepsy with centrotemporal spikes, with the classical forms according to International League Against Epilepsy, and between 4 and 15 years of age, selected from the child neurology outpatient clinic of the Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, and 239 age-matched and educational level-matched (convenience sampling) control children. All children were submitted to the battery of oral volitional movements, which consisted of 44 tests for oral movement (tongue, lip, cheek, jaw, and palate) and 34 phonemes and consonant cluster tasks, with simple and sequenced oral movements. The mean age and standard deviation (SD) of children with epilepsy was 9.08 years (SD 2.55) and of controls 9.61 years (SD 3.12). The results showed significant differences between the groups with a poorer performance of children with epilepsy compared to children without epilepsy in simple and particularly in sequenced movements. These findings can be attributed to the genetically determined immaturity of cortical structures related to motor planning in children with self-limited epilepsy with centrotemporal spikes.

#5

Brain damage associated with apraxia of speech: evidence from case studies.

Neurocase2016 Aug

The site of crucial damage that causes acquired apraxia of speech (AOS) has been debated in the literature. This study presents five in-depth cases that offer insight into the role of brain areas involved in AOS. Four of the examined participants had a primary impairment of AOS either with (n = 2) or without concomitant mild aphasia (n = 2). The fifth participant presented with a lesion relatively isolated to the left anterior insula (AIns-L), damage that is rarely reported in the literature, but without AOS. Taken together, these cases challenge the role of the AIns-L and implicate the left motor regions in AOS.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de epilepsia rolândica-dispraxia da fala.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de epilepsia rolândica-dispraxia da fala

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Novel Candidate Neuromarker of Central Motor Dysfunction in Childhood Apraxia of Speech.
    The Journal of neuroscience : the official journal of the Society for Neuroscience· 2025· PMID 40180575mais citado
  2. Gerstmann's Syndrome and Limb Apraxia: A Single Case Study.
    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists· 2025· PMID 40973146mais citado
  3. Symptomatology and Neuropathology of patients presenting with focal cortical signs.
    Neuropathology : official journal of the Japanese Society of Neuropathology· 2023· PMID 36328774mais citado
  4. Oral dyspraxia in self-limited epilepsy with centrotemporal spikes: a comparative study with a control group.
    Arquivos de neuro-psiquiatria· 2021· PMID 34816971mais citado
  5. Brain damage associated with apraxia of speech: evidence from case studies.
    Neurocase· 2016· PMID 27264534mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:163721(Orphanet)
  2. MONDO:0015587(MONDO)
  3. Epilepsia(PCDT · Ministério da Saúde)
  4. GARD:17002(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q56013736(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de epilepsia rolândica-dispraxia da fala

ORPHA:163721 · MONDO:0015587
🇧🇷 Brasil SUS
Geral
Prevalência
Unknown
Casos
277 casos conhecidos
Herança
Autosomal dominant, X-linked dominant
CID-10
G40.8 · Outras epilepsias
CID-11
Início
Antenatal, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4707308
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades